content

Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate

Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer...

Lonza Capsules and Health Ingredients introduces HPMC double-blinded capsules for clinical trials

A global capsule and equipment developer and manufacturer, Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical...

German Federal Government invests 300 Million Euros in CureVac

The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp...

Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test

llumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. The U.S. FDA issued an EUA for the Illumina COVIDSeqโ„ข Test,...

Creating your Secondary Packaging Strategy

When to Start Creating Your Secondary Packaging Strategy Pharmaceutical and biotechnology companies with a drug product in clinical development are usually focused on a quick...

Naari completes acquisition of ANDAs from Intas Pharmaceuticals

Naari Pharma Private Limited, through its wholly owned subsidiary Naari Pte, has entered into a definitive asset purchase agreement to acquire 10 Abbreviated New...

CPhI Middle East & Africa to debut in Saudi Arabia in 2021

Informa, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, has announced that due to the COVID-19 pandemic, the 2020...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read